Luigi Mangione to use psychiatric defence in healthcare CEO murder case
Luigi Mangione, accused of fatally shooting United Healthcare CEO Brian Thompson in New York City in December 2024, will use a psychiatric defense during his trial. His lawyers informed the judge they will argue Mangione was in a state of "extreme emotional disturbance" at the time of the alleged shooting.

Briefing Summary
AI-generatedLuigi Mangione, accused of fatally shooting United Healthcare CEO Brian Thompson in New York City in December 2024, will use a psychiatric defense during his trial. His lawyers informed the judge they will argue Mangione was in a state of "extreme emotional disturbance" at the time of the alleged shooting. This defense, permitted under New York law, could lead to a manslaughter conviction instead of murder, resulting in a lighter sentence. The article notes that the terms "delay," "deny," and "depose" were found on Mangione's ammunition, potentially referencing anger towards health insurance companies. This plea admits to the act but claims impaired judgment, differing from an insanity defense.
Article analysis
Model · rule-basedKey claims
5 extractedA conviction for manslaughter generally results in a lighter sentence than murder.
Terms 'delay', 'deny', and 'depose' were written on the suspect's ammunition.
New York state law allows murder defendants to argue they cannot be held fully responsible due to extreme emotional disturbance.
Mangione's lawyers informed the judge they will assert he was in a state of 'extreme emotional disturbance' during the shooting.
Luigi Mangione will argue a psychiatric defence during his trial for the murder of United Healthcare CEO Brian Thompson.